Literature DB >> 22626601

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.

I Del Corso, I Puxeddu, E Sardano, S Geraci, M Breggia, V Rocchi, P Migliorini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22626601     DOI： 10.1016/j.anai.2012.03.013

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  6 in total

Review 1.  Angioedema Phenotypes: Disease Expression and Classification.

Authors:  Maddalena Alessandra Wu; Francesca Perego; Andrea Zanichelli; Marco Cicardi
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 2.  Differential Diagnosis and Management Issues of Idiopathic Angiooedema and their Resolution.

Authors:  Andrea Zanichelli; Marta Mansi; Maddalena A Wu; Giulia Azin; Marco Cicardi
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05

3.  Angioedema suppressed by a combination of anti-histamine and leukotriene modifier.

Authors:  Brendan N Wong; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2017-06-13       Impact factor: 3.406

4.  Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.

Authors:  Martin Christian Bucher; Tatjana Petkovic; Arthur Helbling; Urs Christian Steiner
Journal:  Clin Transl Allergy       Date:  2017-08-31       Impact factor: 5.871

5.  Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Authors:  Enrico Brunetta; Dana Shiffer; Marco Folci; Maria I S Achenza; Francesca Puggioni; Enrico Heffler; Raffaello Furlan; Giorgio W Canonica
Journal:  Case Reports Immunol       Date:  2018-07-22

6.  Threatened Respiratory Compromise in the Setting of Isolated Angioedema.

Authors:  Graham S Stephenson; Shahram Lotfipour; Shadi Lahham
Journal:  Clin Pract Cases Emerg Med       Date:  2018-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.